Thursday, 28 October 2021 02:59 GMT

SKIMS Conducts Ist Allogeneic Stem Cell Transplant For Thalassemia Major


(MENAFN- Kashmir Observer) Srinagar: Department of Clinical Haematology, SKIMS has for the first time in Jammu & Kashmir performed a matched sibling Allogeneic Stem Cell/Bone Marrow transplant for a patient suffering from Beta Thalassemia Major. Earlier the Department performed the first Stem/Bone Marrow transplant on patients suffering from Aplastic Anemia.

A statement by SKIMS said that Dr. Javid Rasool Bhat, Prof. & Head Clinical Haematology Department, informed that an eight year old boy from Bihar (class Ist student) diagnosed as Beta Thalassemia major at the age of 8 months was evaluated at AIIMS, New Delhi and was offered Bone Marrow Transplant as curative therapy. The approximate cost of this procedure was quoted as Rs. 10 Lacs.

"Since, the patient belonged to a very poor family and could not afford this costly treatment. His parents brought him to the Department of Clinical Haematology at SKIMS for his treatment. The only curative treatment option for him was Stem Cell Transplantation,' Dr. Javaid said 'Fortunately, his sister's bone marrow stem cells were found to be matching. So, the patient was taken for Allogeneic matched sibling transplant on 30/12/2020. Presently, the patient is doing well and is being planned for discharge in a few days.'

He thanked Director SKIMS for all the support and said this will raise new hope for poor and deserving patients who need Bone Marrow transplant.

Meanwhile Director SKIMS, Dr. A. G. Ahangar, complimented the whole Department of Clinical Haematology including faculty members: Dr. Sajad Geelani, Addl. Prof., Dr. Reashma Roshan, Asstt. Prof. Dr. Afaq Ahmad Khan, Asstt. Prof. and Senior Residents (both Clinical & Lab. side), Resident staff as well as Paramedical Staff of Ward 5P, Technical Staff (Lab. Side) and Office Staff of Clinical Hematology Department including all other supportive Departments.

'SKIMS has created a niche in conducting rare procedures which is benefitting poor patients,' Dr Ahangar added.

Thank you for connecting with us. We will respond to you shortly.

BE PART OF QUALITY JOURNALISM

11https://kashmirobserver.net/wp-content/plugins/nex-formsfalsehttps://kashmirobserver.net/support-our-journalism/redirecthttps://kashmirobserver.net/wp-admin/admin-ajax.phphttps://kashmirobserver.net/2021/01/21/skims-conducts-ist-allogeneic-stem-cell-transplant-for-thalassemia-majoryes1fadeInfadeOut Subscribe Now for NewsletterSubmit

Be Part of Quality Journalism

Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.

ACT NOW
MONTHLY Rs 100 [...]

YEARLY Rs 1000 [...]

LIFETIME Rs 10000 [...]

MENAFN21012021000215011059ID1101471865


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.